Question 1

Can I get a generic semaglutide to save money?

Accepted Answer

Not yet. Semaglutide's patent runs into the early 2030s. Until a generic becomes available, branded Wegovy is priced from $149/month for the pill; the injection is self-pay $349–$399/mo via NovoCare Pharmacy, or $1,349/month at list price.

Question 2

Does my insurance cover semaglutide for weight loss?

Accepted Answer

Coverage varies by plan and has been expanding, though many plans still do not cover GLP-1s for weight loss. Call your insurance company and ask. If denied, ask your doctor to request a prior authorization — many appeals succeed. Medicare doesn't cover weight loss alone, but does cover if you have existing heart disease.

Question 3

Why is the pill priced so differently from the injection?

Accepted Answer

The Wegovy pill (approved late 2025) is priced separately from the injection under Novo Nordisk's own programme. Both contain semaglutide; in trials the pill's weight loss with full adherence (16.6%, OASIS 4) was in a similar range to the injection's (14.9%, STEP 1) — the two trials measured different populations over different time frames, so the figures are not a precise head-to-head.

Question 4

Should I use Ozempic off-label instead of Wegovy to save money?

Accepted Answer

Ozempic is approved for diabetes only, and insurance rarely covers it for weight loss. Wegovy is approved specifically for weight loss and more likely to be covered for that use. The Wegovy pill, self-pay from $149/month, is priced well below either brand's injection list price — and the Wegovy injection itself is self-pay $349–$399/mo via NovoCare Pharmacy rather than its $1,349/month list price.

Question 5

Is compounded semaglutide cheaper and safe?

Accepted Answer

Compounded GLP-1s are sold by some pharmacies, but they are not FDA-approved and their quality control varies — the FDA has issued warnings about some compounded products. The FDA-approved options are the Wegovy pill (self-pay $149–$299/mo) or the injection through NovoCare Pharmacy (self-pay $349–$399/mo, list price $1,349/month).

Question 6

How does the cost of the pill compare to the injection?

Accepted Answer

The pill is self-pay $149–$299/mo by dose, or about $25/month with commercial insurance. The injection is self-pay $349–$399/mo via NovoCare Pharmacy (list price $1,349/month). In trials, the pill produced 16.6% average weight loss with full adherence (OASIS 4) and the injection produced 14.9% (STEP 1) — separate trials, not a head-to-head comparison.

Option	Cost/Month	Notes
List price	$1,349/mo	Pharmacy retail (most people don't pay this)
NovoCare self-pay	$349–$399/mo	Self-pay via NovoCare Pharmacy: $349/month for the 0.25–2.4 mg pens, $399/month for the Wegovy HD 7.2 mg pen. New patients pay a $199/month introductory price for the first two months on the 0.25 mg or 0.5 mg starting doses (offer runs through December 31, 2026, then the regular price applies). ~$25/month with eligible commercial insurance, capped at $100/month in savings. List price ~$1,349/month. The Wegovy pill is priced separately (see the oral pill entry). Per wegovy.com and novocare.com on 17 September 2026.
With insurance	$25/mo	Commercial insurance savings card; capped at $100/month in savings
GoodRx / discount apps	Varies by pharmacy	May be cheaper or more expensive than list price

Option	Cost/Month	Notes
NovoCare self-pay	$149–$299/mo	Priced by dose: $149/month (1.5 mg starting dose), $199/month (4 mg), $299/month (9 mg and 25 mg maintenance doses). ~$25/month with commercial insurance, capped at $100/month in savings. Per novocare.com/wegovy.com on 10 September 2026.
With insurance	$25/mo	Commercial insurance savings card; capped at $100/month in savings

Semaglutide cost — injection vs pill

What you'll actually pay

Detailed pricing

Semaglutide injection (Wegovy / Ozempic)

Semaglutide pill (Wegovy 25mg)

Insurance coverage reality

How to get the lowest cost

Use the pill

Enroll in NovoCare

Check your insurance first

Ask your employer

Request prior authorization appeal

Common questions

Keep reading

Next step most people take